ERIS Lifesciences Sees 6.52% Increase in Stock Price, Outperforms Sector and Sensex

ERIS Lifesciences, a midcap pharmaceutical company, saw a 6.52% increase in its stock price on November 25, 2024. The stock has been performing well in the market, with a 'Hold' call from MarketsMOJO.

Currently, the stock is trading at a price that is 3.54% away from its 52-week high of Rs 1521.05. It has also outperformed the sector by 5.59% today. ERIS Lifesciences has been on a consecutive gain for the last 3 days, with a 8.64% increase in returns during this period.

The stock opened with a gain of 2.38% today and reached an intraday high of Rs 1488.1, which is a 7.9% increase. ERIS Lifesciences is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In comparison to the Sensex performance, ERIS Lifesciences has shown a 1-day performance of 7.31% while the Sensex has only seen a 1.28% increase. In the past month, ERIS Lifesciences has outperformed the Sensex with a 14.54% increase compared to the Sensex's 0.92% increase.

Overall, ERIS Lifesciences has been showing strong performance in the market, making it a promising midcap company in the pharmaceutical industry. Investors may want to keep an eye on this stock as it continues to show positive growth.